Study of Cathepsin B inhibition in VEGFR TKI treated human renal cell carcinoma xenografts

Several therapeutic options are available for metastatic RCC, but responses are almost never complete, and resistance to therapy develops in the vast majority of patients. Consequently, novel treatments are needed to combat resistance to current therapies and to improve patient outcomes. We have app...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncogenesis
Main Authors: Chen, Chun-Hau, Bhasin, Swati, Khanna, Prateek, Joshi, Mukta, Joslin, Patrick MN., Saxena, Ruchi, Amin, Seema, Liu, Suhu, Sindhu, Shreya, Walker, Sarah R., Catalano, Paul, Frank, David A., Alper, Seth L., Bhasin, Manoj, Bhatt, Rupal S.
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group UK 2019
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6386754/
https://ncbi.nlm.nih.gov/pubmed/30796200
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41389-019-0121-7
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares